Granulomatous vasculitis after the Astra-Zeneca anti-SARS-CoV-2 vaccine

Authors :: Nathalie Demoulin
Michel Jadoul
Valentine Gillion
Arnaud Devresse
Selda Aydin
UCL - SSS/IREC/NEFR - Pôle de Néphrologie
UCL - (SLuc) Service de néphrologie
UCL - (SLuc) Service d'anatomie pathologique
Source :: Kidney international, Vol. 100, no. 3, p. 706-707 (2021), Kidney International
Publication Year :: 2021
Publisher :: Elsevier, 2021.
Abstract: TO THE EDITOR : Several reports of newly diagnosed or relapses of immune-mediated renal diseases following vaccination with anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA and AstraZeneca vaccines recently emerged in the litterature. [...]

Subjects :: Vasculitis
2019-20 coronavirus outbreak
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
business.industry
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
COVID-19
medicine.disease
Virology
Nephrology
medicine
Humans
business
Granulomatous vasculitis
Letter to the Editor

Language :: English
Database :: OpenAIRE
Journal :: Kidney international, Vol. 100, no. 3, p. 706-707 (2021), Kidney International
Accession number :: edsair.doi.dedup.....2b73f135711574eb400ce148ac61e307

Tools